A novel artificial endothelial implant may provide a safe, efficient, and cost-effective treatment modality for chronic corneal oedema and dispense the need for donor tissue in severely compromised corneas, according to Gerd Auffarth MD, PhD, FEBO.
© All rights reserved to EyeYon Medical